The fine line between autoimmune and allergic encephalomyelitis

被引：5

作者：

Weiner, HL ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

来源：

NATURE IMMUNOLOGY | 2001年 / 2卷 / 03期

关键词：

D O I：

10.1038/85237

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

What determines whether immune responses against a self-peptide can evoke an anaphylactic response? New evidence describes anaphylaxis that appears to be governed by thymic expression of the self-antigen.

引用

页码：193 / 194

页数：2

共 18 条

[1] High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire [J].

Anderson, AC ;

Nicholson, LB ;

Legge, KL ;

Turchin, V ;

Zaghouani, H ;

Kuchroo, VK .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :761-770

[2] CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].

Balashov, KE ;

Rottman, JB ;

Weiner, HL ;

Hancock, WW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878

[3] Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice [J].

Chen, YH ;

Hancock, WW ;

Marks, R ;

Gonnella, P ;

Weiner, HL .

JOURNAL OF NEUROIMMUNOLOGY, 1998, 82 (02) :149-159

[4] Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy [J].

Comabella, M ;

Balashov, K ;

Issazadeh, S ;

Smith, D ;

Weiner, HL ;

Khoury, SJ .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :671-678

[5] Oral tolerance: Mechanisms and therapeutic applications [J].

Faria, AMC ;

Weiner, HL .

ADVANCES IN IMMUNOLOGY, VOL 73, 1999, 73 :153-264

[6] Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis [J].

Gobbini, MI ;

Smith, ME ;

Richert, ND ;

Frank, JA ;

McFarland, HF .

JOURNAL OF NEUROIMMUNOLOGY, 1999, 99 (01) :142-149

[7] Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years [J].

Johnson, KP ;

Brooks, BR ;

Ford, CC ;

Goodman, A ;

Guarnaccia, J ;

Lisak, RP ;

Myers, LW ;

Panitch, HS ;

Pruitt, A ;

Rose, JW ;

Kachuck, N ;

Wolinsky, JS .

MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (04) :255-266

[8] Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial [J].

Kappos, L ;

Comi, G ;

Panitch, H ;

Oger, J ;

Antel, J ;

Conlon, P ;

Steinman, L .

NATURE MEDICINE, 2000, 6 (10) :1176-1182

[9] ORAL TOLERANCE TO MYELIN BASIC-PROTEIN AND NATURAL RECOVERY FROM EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ARE ASSOCIATED WITH DOWN-REGULATION OF INFLAMMATORY CYTOKINES AND DIFFERENTIAL UP-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND PROSTAGLANDIN-E EXPRESSION IN THE BRAIN [J].

KHOURY, SJ ;

HANCOCK, WW ;

WEINER, HL .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1355-1364

[10] Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease [J].

Lafaille, JJ ;

VandeKeere, F ;

Hsu, AL ;

Baron, JL ;

Haas, W ;

Raine, CS ;

Tonegawa, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :307-312

← 1 2 →